An independent report by Professor Louis Appleby, University of Manchester, Department of Health and Social Care adviser on suicide prevention, examined data provided by NHS England ( NHSE ) on the suicides of young patients in gender services at the Tavistock and Portman NHS Foundation Trust, assessing the evidence of a supposed sharp increase in suicides claimed by campaigners.
Summary of conclusions
- The data does not support the claim that there was a sharp increase in suicides among young patients with gender dysphoria admitted to Tavistock.
- The way this issue has been discussed on social media has been insensitive, distressing and dangerous, and goes against safe suicide reporting guidelines.
- Statements released into the public domain do not meet basic standards for statistical evidence.
- We need to abandon the idea that puberty-blocking drugs are the primary indicator of nonjudgmental acceptance in this area of health care.
- We must ensure high-quality data, in which everyone has confidence, as a basis for improving the safety of this at-risk group of young people.
Suicide risk in gender dysphoria
Evidence on suicide risk in children and young people with gender dysphoria is generally scarce. Most studies are methodologically weak, being based on online surveys and self-selected samples, and coming from biased sources. However, there are good reasons to believe that their risk is elevated compared to other young people. They often experienced prejudice and intimidation, isolation and family conflict. They may have mental health problems such as depression and anxiety. There are high rates of autism. These are known risk factors: suicide in any group is usually the result of multiple risks acting in combination.
It therefore seems reasonable to assume that services offering non-judgmental support can help reduce risk. However, evidence for “gender-affirming care” in the form of puberty-blocking drugs is unreliable. In contrast, a robust study from Finland published earlier this year (Ruuska et al, BMJ Mental Health 2024) reported that suicide risk was reduced after gender reassignment, but that the improvement was explained by treatment of a coexisting mental illness.
Public debate on suicide
Responsible reporting of suicide in the media is an important aspect of suicide prevention and a central feature of the national suicide prevention strategy in England. The guidelines were developed by the Samaritans, originally for the media, but with wider applicability to any public discussion about suicide and increasingly relevant to social media.
Risks include:
- alarming stories of suicides causing distress to people who are themselves at risk
- identification – when someone sees in themselves a link to a person who died by suicide; this leads to:
- clusters of imitation and suicide in people with similar characteristics
As a result, media and social media users are asked to:
- ensure that all claims about suicide are evidence-based and come from a reliable source
- avoid alarming and dramatic language
- avoid the impression that suicide is the expected or probable outcome in certain situations
- avoid oversimplifying suicide by attributing it to a single cause that could be the basis of identification
Affirmations
The claims were brought by legal advocacy group Good Law Project, which is challenging the previous Health Secretary's decision to end private clinics prescribing puberty-blocking drugs to children and young people with gender dysphoria.
The central claim, made on X (formerly known as Twitter), is that there has been a sharp increase in suicides by current and recent Gender Identity Development Service patients ( GIDS ) at Tavistock since a previous restriction of puberty-blocking drugs was introduced, following a High Court decision in a case (Bell v Tavistock) in December 2020. The increase is described as a “wave ” of suicides and “an explosion,” indicating a substantial and, by implication, unmistakable increase. There are multiple references to children dying in the future because they are unable to access puberty-blocking drugs.
This claim is said to be based on unpublished data provided by 2 Tavistock staff members, described as whistleblowers. On Twitter/X the evidence is presented in screenshots of extracts from Tavistock board meeting minutes and other documents. These refer variously to suicides, deaths from unspecified causes and “safety incidents”. One specific claim is that there has been a suicide by a patient on the waiting list of the GIDS in the 3 years before the High Court ruling and 16 deaths (rather than suicides) in the 3 years after the ruling. Whistleblowers are said to have exposed a cover-up of the NHSE .
These statements have been retweeted thousands of times by other activists and members of the public. They have been repeated by some prominent journalists, although there is nothing to suggest that they have examined the evidence themselves. They too have adopted the language of “dying children.”
NHS England's assessment of the Tavistock audit
I have looked at the figures provided by the NHSE on deaths in each year between 2018-19 and 2023-24. They are based on an internal Tavistock audit of patient deaths GIDS current and former patients, divided by age (under 18 or over 18) and cause of death (suicide or other/unconfirmed suicide).
When describing suicide statistics it is important to recognize that the numbers are not dry data, but represent real lives lost.
The numbers are small: under this breakdown, by year, age and cause, the highest count is 2. Conventional practice in presenting small numbers, based on Office for National Statistics guidelines, is not to present smaller numbers to 3, to avoid the possible identification of individuals. In this review I only refer to aggregate figures.
Over this 6-year period the data shows a total of 12 suicides: 6 among those under 18, 6 among those over 18. In the 3 years before 2020-21, there were 5 suicides, compared to 7 in the 3 years after. This is essentially not a difference, taking into account expected fluctuations in small numbers, and would not reach statistical significance. Specifically, among those under 18, there were 3 suicides before and 3 after 2020-21.
Alongside the figures, there is a summary of the problems faced by the deceased young people. These include mental illness, traumatic experiences, family breakdown and foster care or referral to children's services.
These figures clearly do not support the main claim that suicides have soared since the High Court ruling. They do not support the claim of one death on the waiting list before and 16 after the ruling. The information confirms the multiple factors that contribute to the risk of suicide in this group.
This analysis has limitations, which reflect the quality and comprehensiveness of the data. First, the figures refer to “NHS years”, April to March, so the timing of the High Court ruling does not fall neatly between years. Secondly, these figures do not include details of where in the care pathway patients were at when they died. Third, they provide no further information on deaths described as due to other causes or “not confirmed as suicide.”
I also had the opportunity to view the Tavistock internal audit on which the summary is based NHSE . There are small differences in the time period covered and in some figures. There is more information on the care received and dates of death.
The review suggests that some of the deaths listed as “not confirmed as suicide” were likely unnatural deaths, possibly implicating suicide as the cause, although there are few details. Including these cases, however, would not affect the overall conclusions because, with small numbers, single-digit fluctuations can be expected.
The audit confirms the multiple risks faced by many patients. It shows that deaths occurred at different points in the care system, including waiting, hospital stay and post-discharge. Concerns are raised about patients waiting or transitioning from one care environment to another. Any causal attribution to any element of care would go beyond the data and should be avoided.
Figures NCMD
The NHSE also provided data from the National Child Mortality Database ( NCMD ). These are suspected suicides in all people under the age of 18 in England. Cases are reported to the NCMD with additional information about deceased individuals, including the presence of distress related to gender identity.
References to gender discomfort in the cases NCMD they occur more frequently in more recent years, with the highest annual figure in 2021-22. At this stage it is not possible to link these cases to the audit GIDS . There is no information on whether these young people were reporting gender dysphoria, seeking help from the NHS or were in contact with Tavistock. The increase is more likely to reflect young people increasingly expressing their distress through gender conflict and more frequent recognition by professionals.
NCMD also reports a higher number of suicides among under-18s overall in 2021-22. This may be the result of random fluctuations in small numbers, but it coincides with a crucial year in the COVID-19 pandemic, when restrictions may have negatively affected the emotional health of some young people, such as autistic people. The co-occurrence of autism and gender dysphoria is well established.
In summary, I find the data unlikely NCMD higher have some link to the availability of puberty blockers, but further investigation is needed.
Conclusions
1. The data does not support the claim that there has been a sharp increase in suicides among young patients attending Tavistock gender services since the High Court ruling in 2020 or any other recent date. The figures for the 6 years covered by this review are 12 suicides in total, 2 per year on average, of which half were under 18 years of age. With small numbers, single-digit differences can be expected and causal explanations are not reliable.
Deceased patients were at different points in the care system, including post-discharge, suggesting there is no consistent link to one aspect of care. They had multiple social and clinical risk factors for suicide.
However, it is likely that an increase has occurred over a longer period, as young people at risk increasingly have gender dysphoria and hospitalizations have increased. the GIDS centers.
There is a certain degree of uncertainty about deaths recorded as “unconfirmed suicide”. It is possible that more information on these cases could lead to revised figures for individual years, but the numbers remain too small to influence my conclusions.
2. The way this issue has been discussed on social media has been insensitive, distressing and dangerous, and goes against safe suicide reporting guidelines. One risk is that young people and their families will be terrified by predictions of suicide as inevitable without puberty blockers: some of the responses on social media demonstrate this.
Another is identification: Already distressed teenagers hear the message that “people like you, facing similar problems, are committing suicide,” which leads to imitative suicide or self-harm, to which young people are particularly susceptible.
Then there is the insensitivity of “dead baby” rhetoric. Suicide should not be a slogan or a means to win an argument. For families of 200 teenagers a year in England, it is devastating and all too real.
3. The claims that have been made public do not meet the basic standards for statistical evidence. To be reliable, evidence must be objective, impartial and open to independent examination. They must admit uncertainty.
Campaign groups are often selective about evidence – there is nothing wrong with this as long as it doesn't become misleading and potentially harmful. The evidence released for an “explosion” of suicides is not impartial nor has it been independently verified. There appears to be no suicide expertise behind the claims.
4. The suicide of any young person is a profound tragedy: it should be seen as an indictment of our society. Young people with gender dysphoria may have experienced ostracism and abuse, and their suffering is likely to increase if services are perceived as rejecting. It's unfortunate that puberty-blocking drugs have become the go-to issue, the difference between acceptance and non-acceptance. We need to move away from this perception among patients, staff and the public.
This is a group of young people who need compassion and safety, qualified clinical assessment, early treatment for mental illnesses such as depression, support within their families, schools and online, and an expectation of recovery and a fulfilling future. It is vital that these are the assurances that the NHS and its partner agencies are able to deliver.
5. Ultimately, this is about a group of young people at risk of suicide and our collective responsibility for their safety. This means specialist healthcare services with the capacity to respond to growing demand and appropriate expertise in general services. It means measured public discourse, ensuring we do not fuel prejudice or cause unnecessary alarm to young people and their families.
We also need to make sure we have high-quality data that everyone has confidence in. The number of deaths should be monitored, not only in gender services but also in other traditional databases, as is happening now in NCMD and in my unit, the National Confidential Inquiry. Future prevention will depend on this.
the original report here
translation by Marina Terragni
This article is produced through voluntary work.
Much of the news you read here you won't find in any other media.
If you think our work is useful, thank you if you can support us.
Even the smallest contribution is precious!

